• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

仅表现为肾病的非典型法布里病α-半乳糖苷酶A基因中的点突变。

Point mutation in the alpha-galactosidase A gene of atypical Fabry disease with only nephropathy.

作者信息

Sawada K, Mizoguchi K, Hishida A, Kaneko E, Koide Y, Nishimura K, Kimura M

机构信息

First Department of Medicine, Hamamatsu University School of Medicine, Japan.

出版信息

Clin Nephrol. 1996 May;45(5):289-94.

PMID:8738659
Abstract

A point mutation in exon 6 of the alpha-galactosidase A gene (alpha-GAL A) was found in a Japanese hemizygous male without typical manifestations of Fabry disease other than renal involvement. This 45-year-old man developed moderate proteinuria and was diagnosed with Fabry disease on the basis of renal histologic findings and prominent decreases in alpha-GAL A activity in his plasma, urine, leukocytes, and skin fibroblasts. Determination of the cDNA sequence of his alpha-GAL A gene revealed substitution of a G to A in codon 301, resulting in a glutamine rather than an arginine residue. Our case is unique in that this patient only demonstrated renal manifestations while all other reported patients with atypical Fabry disease, including a case with the identical point mutation, present with a cardiomyopathy. Direct DNA sequencing of exon 6 and measurement of alpha-GAL A activity among the patient's family confirmed that the mutation was transmitted from his mother.

摘要

在一名日本半合子男性中发现了α-半乳糖苷酶A基因(α-GAL A)第6外显子的一个点突变,该男性除肾脏受累外无典型的法布里病表现。这名45岁的男性出现中度蛋白尿,根据肾脏组织学检查结果以及其血浆、尿液、白细胞和皮肤成纤维细胞中α-GAL A活性显著降低,被诊断为法布里病。对其α-GAL A基因的cDNA序列测定显示,密码子301处的G被A取代,导致产生一个谷氨酰胺残基而非精氨酸残基。我们的病例很独特,因为该患者仅表现出肾脏症状,而所有其他报道的非典型法布里病患者,包括一例具有相同点突变的病例,均表现为心肌病。对该患者家族成员的第6外显子进行直接DNA测序以及测量α-GAL A活性,证实该突变是由其母亲遗传而来。

相似文献

1
Point mutation in the alpha-galactosidase A gene of atypical Fabry disease with only nephropathy.仅表现为肾病的非典型法布里病α-半乳糖苷酶A基因中的点突变。
Clin Nephrol. 1996 May;45(5):289-94.
2
A missense mutation, A156T, in the alpha-galactosidase A gene causes typical Fabry disease.α-半乳糖苷酶A基因中的错义突变A156T会导致典型的法布里病。
Clin Nephrol. 2001 Mar;55(3):243-7.
3
Identification of a novel point mutation (S65T) in alpha-galactosidase A gene in Chinese patients with Fabry disease. Mutations in brief no. 169. Online.中国法布里病患者α-半乳糖苷酶A基因新的点突变(S65T)的鉴定。简短突变报道第169号。在线发表。
Hum Mutat. 1998;11(4):328-30. doi: 10.1002/(SICI)1098-1004(1998)11:4<328::AID-HUMU11>3.0.CO;2-N.
4
Absence of cornea verticillata in hemizygotes of a novel mutation in fabry disease.法布里病新突变半合子中无涡状角膜。
Cornea. 2008 Sep;27(8):970-2. doi: 10.1097/ICO.0b013e318172fbe2.
5
Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography.通过变性高效液相色谱法检测导致法布里病的α-半乳糖苷酶A突变
Hum Mutat. 2005 Mar;25(3):299-305. doi: 10.1002/humu.20144.
6
Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma.法布里病:D313Y是一种α-半乳糖苷酶A序列变体,可导致血浆中的假性活性不足。
Mol Genet Metab. 2003 Nov;80(3):307-14. doi: 10.1016/S1096-7192(03)00136-7.
7
Fabry disease in a female patient due to a de novo point mutation at position 691 of exon 5.
Eur J Med Res. 2006 Jul 31;11(7):306-8.
8
New mutation in female patient with renal variant of Fabry disease and HIV.女性 Fabry 病肾变异型合并 HIV 感染者的新突变。
J Nephrol. 2010 Mar-Apr;23(2):231-3.
9
Mutation analysis of alpha-galactosidase a gene in Hungarian Fabry patients.
Ideggyogy Sz. 2012 Jan 30;65(1-2):35-9.
10
A novel alpha-galactosidase a mutant (M42L) identified in a renal variant of Fabry disease.在法布里病的一种肾脏变异型中鉴定出的一种新型α-半乳糖苷酶A突变体(M42L)。
Am J Kidney Dis. 2004 Nov;44(5):e85-9.

引用本文的文献

1
A Renal Variant of Fabry Disease Diagnosed by the Presence of Urinary Mulberry Cells.通过尿液中桑葚状细胞诊断出的法布里病肾脏变异型。
Intern Med. 2016;55(23):3475-3478. doi: 10.2169/internalmedicine.55.7367. Epub 2016 Dec 1.
2
Coincidental finding of Fabry's disease in a patient with IgA nephropathy.在一名IgA肾病患者中偶然发现法布里病。
NDT Plus. 2010 Oct;3(5):443-6. doi: 10.1093/ndtplus/sfq108. Epub 2010 Jun 16.
3
Idiopathic small fiber neuropathy: phenotype, etiologies, and the search for fabry disease.特发性小纤维神经病:表型、病因学和法布里病的研究。
J Clin Neurol. 2014 Apr;10(2):108-18. doi: 10.3988/jcn.2014.10.2.108. Epub 2014 Apr 23.
4
Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease.酶替代疗法治疗法布里病肾病的安全性和有效性。
Biologics. 2008 Dec;2(4):823-43. doi: 10.2147/btt.s3770.
5
Fabry disease: correlation between structural changes in alpha-galactosidase, and clinical and biochemical phenotypes.法布里病:α-半乳糖苷酶结构变化与临床及生化表型之间的相关性
Hum Genet. 2005 Aug;117(4):317-28. doi: 10.1007/s00439-005-1300-5. Epub 2005 May 28.
6
A novel 6 bp insertion in exon 7 associated with an unusual phenotype in a family with Fabry disease.
J Inherit Metab Dis. 2002 Dec;25(8):695-6. doi: 10.1023/a:1022833332162.